Xu, Mingtong
Sun, Kan
Xu, Wenjie
Wang, Chuan
Yan, Dewen
Li, Shu
Cong, Li
Pi, Yinzhen
Song, Weihong
Sun, Qingyuan
Xiao, Rijun
Peng, Weixia
Wang, Jianping
Peng, Hui
Zhang, Yawei
Duan, Peng
Zhang, Meiying
Liu, Jianying
Huang, Qingmei
Li, Xuefeng
Bao, Yan
Zeng, Tianshu
Wang, Kun
Qin, Li
Wu, Chaoming
Deng, Chunying
Huang, Chenghu
Yan, Shuang
Zhang, Wei
Li, Meizi
Sun, Li
Wang, Yanjun
Li, HongMei
Wang, Guang
Pang, Shuguang
Zheng, Xianling
Wang, Haifang
Wang, Fujun
Su, Xiuhai
Ma, Yujin
Zhang, Wei
Li, Ziling
Xie, Zuoling
Xu, Ning
Ni, Lin
Zhang, Li
Deng, Xiangqun
Pan, Tianrong
Dong, Qijuan
Wu, Xiaohong
Shen, Xingping
Zhang, Xin
Zou, Qijing
Jiang, Chengxia
Xi, Jue
Ma, Jianhua
Sun, Jingchao
Yan, Li
Funding for this research was provided by:
Shenzhen Science and Technology Program for Undertake the National Science and Technology Major Project (CJGJZD20210408091600001)
Shenzhen Salubris Pharmaceuticals Co.,Ltd (SAL067)
Article History
Received: 6 April 2023
Accepted: 21 September 2023
First Online: 9 October 2023
Declarations
:
: The study was approved by the ethics committee at each study site and conducted according to the Declaration of Helsinki, Guidelines for Good Clinical Practice, and local laws and regulations. All patients provided written informed consents.
: All authors believe that the manuscript represents valid work and have reviewed and approved the final version. The work has not been published previously, and is not under consideration for publication elsewhere, in part or in whole.
: Wenjie Xu and Jingchao Sun were reported being employed at Shenzhen Salubris Pharmaceuticals. The remaining authors declare no competing interests.